Evaluation of Serum Vascular Adhesion Protein-1 as a Potential Biomarker in Thyroid Cancer

Vascular adhesion protein-1 (VAP-1) is a glycoprotein that mediates tissue-selective lymphocyte adhesion. The prognostic value of VAP-1 has been determined in gastric cancer. The aim of this study was to evaluate the changes and the predictive value of serum VAP-1 in patients with thyroid cancer. A...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhigang Hu, Pengxin Zhao, Kaili Zhang, Leilei Zang, Haiying Liao, Weiyuan Ma
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2016/6312529
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551947286085632
author Zhigang Hu
Pengxin Zhao
Kaili Zhang
Leilei Zang
Haiying Liao
Weiyuan Ma
author_facet Zhigang Hu
Pengxin Zhao
Kaili Zhang
Leilei Zang
Haiying Liao
Weiyuan Ma
author_sort Zhigang Hu
collection DOAJ
description Vascular adhesion protein-1 (VAP-1) is a glycoprotein that mediates tissue-selective lymphocyte adhesion. The prognostic value of VAP-1 has been determined in gastric cancer. The aim of this study was to evaluate the changes and the predictive value of serum VAP-1 in patients with thyroid cancer. A total of 126 patients with thyroid nodules and 53 healthy controls participated in this study. The patients were further divided into subgroup 1 (69 cases with benign thyroid nodules) and subgroup 2 (57 cases with thyroid cancer). Serum VAP-1 was measured by time-resolved immunofluorometric assay. Diagnostic value of presurgical VAP-1 for thyroid cancer was conducted by receiver operating characteristic (ROC) curves. Serum levels of VAP-1 were significantly lower in thyroid cancer group than in healthy control and benign thyroid nodule groups. VAP-1 concentrations negatively correlated with serum thyroglobulin (Tg) levels in thyroid cancer patients (r=-0.81; p<0.001). The optimum cut-off value of VAP-1 was 456.6 ng/mL with a 77.4% specificity and 66.7% sensitivity for thyroid cancer diagnosis. Serum VAP-1 decreased in thyroid cancer patients and VAP-1 could be a potential useful adjunct biomarker in the diagnosis of thyroid cancer.
format Article
id doaj-art-5544ee53e81b40d49c494e166142fa51
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-5544ee53e81b40d49c494e166142fa512025-02-03T05:59:53ZengWileyInternational Journal of Endocrinology1687-83371687-83452016-01-01201610.1155/2016/63125296312529Evaluation of Serum Vascular Adhesion Protein-1 as a Potential Biomarker in Thyroid CancerZhigang Hu0Pengxin Zhao1Kaili Zhang2Leilei Zang3Haiying Liao4Weiyuan Ma5The Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, Hebei 050000, ChinaThe Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, Hebei 050000, ChinaThe Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, Hebei 050000, ChinaThe Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, Hebei 050000, ChinaThe Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, Hebei 050000, ChinaThe Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, Hebei 050000, ChinaVascular adhesion protein-1 (VAP-1) is a glycoprotein that mediates tissue-selective lymphocyte adhesion. The prognostic value of VAP-1 has been determined in gastric cancer. The aim of this study was to evaluate the changes and the predictive value of serum VAP-1 in patients with thyroid cancer. A total of 126 patients with thyroid nodules and 53 healthy controls participated in this study. The patients were further divided into subgroup 1 (69 cases with benign thyroid nodules) and subgroup 2 (57 cases with thyroid cancer). Serum VAP-1 was measured by time-resolved immunofluorometric assay. Diagnostic value of presurgical VAP-1 for thyroid cancer was conducted by receiver operating characteristic (ROC) curves. Serum levels of VAP-1 were significantly lower in thyroid cancer group than in healthy control and benign thyroid nodule groups. VAP-1 concentrations negatively correlated with serum thyroglobulin (Tg) levels in thyroid cancer patients (r=-0.81; p<0.001). The optimum cut-off value of VAP-1 was 456.6 ng/mL with a 77.4% specificity and 66.7% sensitivity for thyroid cancer diagnosis. Serum VAP-1 decreased in thyroid cancer patients and VAP-1 could be a potential useful adjunct biomarker in the diagnosis of thyroid cancer.http://dx.doi.org/10.1155/2016/6312529
spellingShingle Zhigang Hu
Pengxin Zhao
Kaili Zhang
Leilei Zang
Haiying Liao
Weiyuan Ma
Evaluation of Serum Vascular Adhesion Protein-1 as a Potential Biomarker in Thyroid Cancer
International Journal of Endocrinology
title Evaluation of Serum Vascular Adhesion Protein-1 as a Potential Biomarker in Thyroid Cancer
title_full Evaluation of Serum Vascular Adhesion Protein-1 as a Potential Biomarker in Thyroid Cancer
title_fullStr Evaluation of Serum Vascular Adhesion Protein-1 as a Potential Biomarker in Thyroid Cancer
title_full_unstemmed Evaluation of Serum Vascular Adhesion Protein-1 as a Potential Biomarker in Thyroid Cancer
title_short Evaluation of Serum Vascular Adhesion Protein-1 as a Potential Biomarker in Thyroid Cancer
title_sort evaluation of serum vascular adhesion protein 1 as a potential biomarker in thyroid cancer
url http://dx.doi.org/10.1155/2016/6312529
work_keys_str_mv AT zhiganghu evaluationofserumvascularadhesionprotein1asapotentialbiomarkerinthyroidcancer
AT pengxinzhao evaluationofserumvascularadhesionprotein1asapotentialbiomarkerinthyroidcancer
AT kailizhang evaluationofserumvascularadhesionprotein1asapotentialbiomarkerinthyroidcancer
AT leileizang evaluationofserumvascularadhesionprotein1asapotentialbiomarkerinthyroidcancer
AT haiyingliao evaluationofserumvascularadhesionprotein1asapotentialbiomarkerinthyroidcancer
AT weiyuanma evaluationofserumvascularadhesionprotein1asapotentialbiomarkerinthyroidcancer